About
Lipophilic, blood-brain-barrier passing, antioxidant Emeramide
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
197
By Phase
PHASE2/PHASE3: 1PHASE2: 4
By Status
COMPLETED: 4RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT04183595Lead Sponsor
NBMI Treatment in Patients With Mercury Toxicity
PHASE2/PHASE3Recruiting
116 participants
Started: Nov 22, 2023 · Completed: Nov 22, 2024
NCT04092205Lead Sponsor
Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation
PHASE2Completed
13 participants
Started: Nov 21, 2019 · Completed: Aug 30, 2020
NCT04184063Lead Sponsor
Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)
PHASE2Completed
20 participants
Started: Sep 16, 2019 · Completed: Jun 30, 2021
NCT03123692Lead Sponsor
NBMI - Clinical Study on COPD
PHASE2Completed
12 participants
Started: Jan 1, 2017 · Completed: Jun 30, 2018
NCT02486289Lead Sponsor
Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication
PHASE2Completed
36 participants
Started: Aug 31, 2015 · Completed: Apr 30, 2016
Locations (1)
Headquarters
Dublin, Ireland
Map
Loading map...